Gaëlle Clavel

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network

Hélène Vallet, P. Sève, Lucie Biard et al. · Arthritis & Rheumatology · 2016 · 170 citations · Full text

Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction

Gaëlle Clavel, Natacha Bessis, Delphine Lemeiter et al. · Clinical Immunology · 2007 · 80 citations

Immunology, Pathology, Joint Destruction +18

Musculoskeletal Ultrasonography in Healthy Subjects and Ultrasound Criteria for Early Arthritis (The ESPOIR Cohort)

Florence Millot, Gaëlle Clavel, Fabien Etchepare et al. · The Journal of Rheumatology · 2011 · 61 citations · Full text

Early phase clinical and biological markers associated with subclinical atherosclerosis measured at 7 years of evolution in an early inflammatory arthritis cohort

T. Vandhuick, Yannick Allanore, D. Borderie et al. · HAL (Le Centre pour la Communication Scientifique Directe) · 2016 · 46 citations